Pharmacological Treatments against COVID-19 in Pregnant Women
The recent respiratory virus known as SARS-CoV-2 has caused millions of deaths worldwide, causing great uncertainty due to the lack of a specific treatment, which has been mitigated by the use of various drugs traditionally used against other types of pathologies. Pregnancy presents special physiolo...
Guardado en:
Autores principales: | Ana Arco-Torres, Jonathan Cortés-Martín, María Isabel Tovar-Gálvez, María Montiel-Troya, Blanca Riquelme-Gallego, Raquel Rodríguez-Blanque |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/27e679a1e9484b3f84a849e6ec623d02 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
COVID-19 Delta Variant-of-Concern: A Real Concern for Pregnant Women With Gestational Diabetes Mellitus
por: Md Mahfuz Al Mamun, et al.
Publicado: (2021) -
Differences in pregnancy and perinatal outcomes among symptomatic versus asymptomatic COVID-19-infected pregnant women: a systematic review and meta-analysis
por: Durray Shahwar A. Khan, et al.
Publicado: (2021) -
Impact of the SARS-CoV-2 pandemic and first lockdown on pregnancy monitoring in France: the COVIMATER cross-sectional study
por: Alexandra Doncarli, et al.
Publicado: (2021) -
Prevalence and Risk Factors of SARS-CoV-2 Infection among Parturients and Newborns from Luanda, Angola
por: Cruz S. Sebastião, et al.
Publicado: (2021) -
Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis
por: Vineet D. Menachery, et al.
Publicado: (2017)